Effects of sulfasalazine and tofacitinib on the protein profile of articular chondrocytes. Issue 5 (September 2014)
- Record Type:
- Journal Article
- Title:
- Effects of sulfasalazine and tofacitinib on the protein profile of articular chondrocytes. Issue 5 (September 2014)
- Main Title:
- Effects of sulfasalazine and tofacitinib on the protein profile of articular chondrocytes
- Authors:
- Endo, Wataru
Arito, Mitsumi
Sato, Toshiyuki
Kurokawa, Manae S.
Omoteyama, Kazuki
Iizuka, Nobuko
Okamoto, Kazuki
Suematsu, Naoya
Nakamura, Hiroshi
Beppu, Moroe
Kato, Tomohiro - Abstract:
- <abstract> <title>Abstract</title> <p> <italic>Objective.</italic> Sulfasalazine (SSZ) and tofacitinib are effective for treating rheumatoid arthritis, however, their effects on chondrocytes have not been fully understood. We here tried to elucidate their effects on chondrocyte proteins.</p> <p> <italic>Methods.</italic> We treated chondrocytes from five osteoarthritis patients with IL-1β, IL-1β+ SSZ, IL-1β+ tofacitinib, SSZ alone, and tofacitinib alone. Then, we compared protein profiles of the chondrocytes using two-dimensional differential gel electrophoresis. Further, we identified altered proteins by mass spectrometry.</p> <p> <italic>Results.</italic> Out of 892 detected protein spots, the IL-1β stimulation changed intensity of 43 spots more than 1.3-fold or less than 1/1.3-fold significantly. SSZ suppressed the IL-1β-induced intensity alteration in 16 (37%) out of the 43 protein spots. Tofacitinib suppressed the IL-1β-induced alteration in 4 (9.3%) out of the 43 spots. The production of AMP deaminase 2 and procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 were increased by IL-1β and the increase was suppressed by SSZ and by tofacitinib. SSZ alone altered intensity of 273 (31%) out of the 852 spots significantly, whereas tofacitinib alone altered intensity of only 24 (2.7%) out of them.</p> <p> <italic>Conclusion.</italic> SSZ and, to lesser extent, tofacitinib suppress the effects of IL-1β on the protein profiles of chondrocytes. Our data would promote understanding<abstract> <title>Abstract</title> <p> <italic>Objective.</italic> Sulfasalazine (SSZ) and tofacitinib are effective for treating rheumatoid arthritis, however, their effects on chondrocytes have not been fully understood. We here tried to elucidate their effects on chondrocyte proteins.</p> <p> <italic>Methods.</italic> We treated chondrocytes from five osteoarthritis patients with IL-1β, IL-1β+ SSZ, IL-1β+ tofacitinib, SSZ alone, and tofacitinib alone. Then, we compared protein profiles of the chondrocytes using two-dimensional differential gel electrophoresis. Further, we identified altered proteins by mass spectrometry.</p> <p> <italic>Results.</italic> Out of 892 detected protein spots, the IL-1β stimulation changed intensity of 43 spots more than 1.3-fold or less than 1/1.3-fold significantly. SSZ suppressed the IL-1β-induced intensity alteration in 16 (37%) out of the 43 protein spots. Tofacitinib suppressed the IL-1β-induced alteration in 4 (9.3%) out of the 43 spots. The production of AMP deaminase 2 and procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 were increased by IL-1β and the increase was suppressed by SSZ and by tofacitinib. SSZ alone altered intensity of 273 (31%) out of the 852 spots significantly, whereas tofacitinib alone altered intensity of only 24 (2.7%) out of them.</p> <p> <italic>Conclusion.</italic> SSZ and, to lesser extent, tofacitinib suppress the effects of IL-1β on the protein profiles of chondrocytes. Our data would promote understanding of effects of the drugs on chondrocytes.</p> </abstract> … (more)
- Is Part Of:
- Modern rheumatology. Volume 24:Issue 5(2014)
- Journal:
- Modern rheumatology
- Issue:
- Volume 24:Issue 5(2014)
- Issue Display:
- Volume 24, Issue 5 (2014)
- Year:
- 2014
- Volume:
- 24
- Issue:
- 5
- Issue Sort Value:
- 2014-0024-0005-0000
- Page Start:
- 844
- Page End:
- 850
- Publication Date:
- 2014-09
- Subjects:
- Rheumatology -- Periodicals
616.723005 - Journal URLs:
- http://firstsearch.oclc.org ↗
https://academic.oup.com/mr ↗
https://www.tandfonline.com/journals/imor20 ↗
http://informahealthcare.com/loi/mor ↗
http://link.springer-ny.com/link/service/journals/10165/index.htm ↗
http://link.springer.com/journal/10165 ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/14397595.2013.864225 ↗
- Languages:
- English
- ISSNs:
- 1439-7595
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5895.300000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3669.xml